Clinical Trials Browser

Phase 2 × Metastatic Pancreatic Adenocarcinoma × Gemcitabine × Clear all

NCT06576115 2025-11-05

Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer

Phase 2 Recruiting

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT02383433 2023-10-23

Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer

Phase 2 Terminated

2 enrolled 8 charts

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT01729481 2017-07-19

ML22774

Phase 2 Unknown

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma